search icon

    Market Snapshot

    • S&P Futures

      3,914.75

    • Dow Futures

      31,478

    • Nasdaq Futures

      12,132.75

    blog search icon

    Bausch Health Companies Inc.

    (NYSE:BHC)

    $7.27

    $0.21

    2.97%

    Bausch Health Companies Inc. Chart

    BHC Stock Price Today

    Bausch Health Companies Inc. (BHC) stock rallied over 2.97% intraday to trade at $7.27 a share on NYSE. The stock opened with a gain of 3.27% at $7.05 and touched an intraday high of $7.28, rising 2.97% against the last close of $7.06. The stock went to a low of $6.88 during the session.

    Stock Snapshot

    $7.06

    Prev. Close

    2.6 Billion

    Market Cap

    $6.88

    Day Low

    $7.05

    Open

    360.8 Million

    Number of Shares

    $7.28

    Day High

    -

    P/E ratio

    -1.14

    EPS (TTM)

    1.62

    Cash Flow per Share

    4.21

    Free Float in %

    -0.57

    Book Value

    5,487,007

    Volume

    Bausch Health Companies Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-23$7.05$7.28$6.88$7.275,506,000
    2022-06-22$7.04$7.39$7.01$7.064,914,400
    2022-06-21$7.46$7.6$7.11$7.25,962,800
    2022-06-17$7.24$7.49$7.15$7.365,141,100
    2022-06-16$7.57$7.62$7.21$7.285,361,100
    2022-06-15$7.45$7.96$7.45$7.845,689,900
    2022-06-14$7.56$7.62$7.26$7.45,133,500
    2022-06-13$7.86$7.93$7.45$7.586,332,200
    2022-06-10$8.15$8.23$7.92$8.036,261,900
    2022-06-09$8.92$8.98$8.36$8.386,534,300

    Contact Details

    2150 St. ElzEar Boulevard West
    Laval, QC H7L 4A8
    Canada

    Webiste:BHC

    514-744-6792

    Company Information

    Employees-

    Beta1.71

    Sales or Revenue8.43 Billion

    5Y Sales Change-2.70%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryPharmaceuticals

    About Company

    Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

    Frequently Asked Questions

    icon

    What is the current Bausch Health Companies Inc. (BHC) stock price?

    Bausch Health Companies Inc. (NYSE: BHC) stock price is $7.27 as of the last check on Thursday, June 23. During the trading session, BHC stock reached the peak price of $7.28 while $6.88 was the lowest point it dropped to.

    icon

    BHC's industry and sector of operation?

    The NYSE listed BHC is part of Pharmaceuticals industry that operates in the broader Health Care sector. Bausch Health Companies Inc. , together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology.

    icon

    Who are the executives of BHC?

    Mr. Joseph C. Papa
    Chairman & CEO
    Ms. Christina M. Ackermann
    Exec. VP, Gen. Counsel & Head of Commercial Operations
    Mr. Paul S. Herendeen
    Exec. VP and Advisor to Chairman & CEO
    Mr. Thomas J. Appio
    Pres & Co-Head Bausch + Lomb/International

    icon

    What is the BHC stock price today?

    BHC stock traded closed the last session at $7.27, which is $0.21 or 2.97% lower than its previous close of $7.06. BHC's current trading price is 3.71% lower than its 52-week high of $30.30 where as its distance from 52-week low of 7.01% is -76.01%.

    icon

    How many employees does BHC have?

    Number of BHC employees currently stands at -. BHC operates from 2150 St. ElzEar Boulevard West, Laval, QC H7L 4A8, Canada.

    icon

    Link for BHC official website?

    Official Webiste of $BHC is: https://www.bauschhealth.com

    icon

    How do I contact BHC?

    BHC could be contacted at BHC operates from 2150 St. ElzEar Boulevard West, Laval, QC H7L 4A8, Canada, or at phone #514-744-6792 and can also be accessed through its website.

    icon

    How many shares of BHC are traded daily?

    BHC stock volume for the day was 5,487,007 shares while in the previous session number of BHC shares traded was 5,506,000 . The average number of BHC shares traded daily for last 3 months was 6.85 Million.

    icon

    How much did BHC change today?

    The percentage change in BHC stock occurred in the recent session was 2.97% while the dollar amount for the price change in BHC stock was $0.21.

    icon

    What price range BHC stock been trading in?

    In the recent session, the day high for BHC stock was $7.28 while the low for BHC stock touched on the day was $6.88.

    icon

    What is the market cap of BHC currently?

    The market value of BHC currently stands at 2.6 Billion with its latest stock price at $7.27 and 360.8 Million of its shares outstanding.